首页> 美国卫生研究院文献>Molecules >Discovery of Hybrid Dual N-Acylhydrazone and Diaryl Urea Derivatives as Potent Antitumor Agents: Design Synthesis and Cytotoxicity Evaluation
【2h】

Discovery of Hybrid Dual N-Acylhydrazone and Diaryl Urea Derivatives as Potent Antitumor Agents: Design Synthesis and Cytotoxicity Evaluation

机译:混合双N-酰基Ac和二芳基尿素衍生物作为有效抗肿瘤剂的发现:设计合成和细胞毒性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Based on the hybrid pharmacophore design concept, a novel series of dual diaryl urea and N-acylhydrazone derivatives were synthesized and evaluated for their in vitro cytotoxicity by the standard MTT assay. The pharmacological results indicated that most compounds exhibited moderate to excellent activity. Moreover, compound >2g showed the most potent cytotoxicity against HL-60, A549 and MDA-MB-231 cell lines, with IC50 values of 0.22, 0.34 and 0.41 μM, respectively, which was 3.8 to 22.5 times more active than the reference compounds sorafenib and PAC-1. The promising compound >2g thus emerges as a lead for further structural modifications.
机译:基于混合药效团设计概念,合成了一系列新的双二芳基尿素和N-酰基hydr衍生物,并通过标准MTT分析评估了它们的体外细胞毒性。药理结果表明大多数化合物表现出中等至优异的活性。此外,化合物> 2g 对HL-60,A549和MDA-MB-231细胞系表现出最强的细胞毒性,IC50值分别为0.22、0.34和0.41μM,是3.8至22.5倍比参考化合物索拉非尼和PAC-1具有更高的活性。因此很有希望的化合物> 2g 成为了进一步结构修饰的先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号